(Q40633527)

22 September 2017

1 reference

title

Management of the nephrotic syndrome in children (English)

1 reference

22 September 2017

1 reference

Rance CP

1

1 reference

22 September 2017

Arbus GS

series ordinal

2

1 reference

22 September 2017

Balfe JW

series ordinal

3

1 reference

22 September 2017

publication date

1 November 1976

1 reference

Pediatric Clinics of North America

22 September 2017

published in

1 reference

22 September 2017

volume

23

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

735-750

1 reference

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

The displacement of serum water by the lipids of hyperlipemic serum; a new method for the rapid determination of serum water

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Renal Handling of Creatinine in Nephrotic and Non-Nephrotic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

An international cooperative study, societies of paediatric nephrology, and Henry L. Barnett.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Long-term assessment of steroid therapy in childhood nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Malignant mixed mullerian tumor of the cervix following cyclophosphamide therapy for nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Return of spermatogenesis after stopping cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Histology, protein clearances, and response to treatment in the nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Membranoproliferative glomerulonephritis and persistent hypocomplementaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

"CONTRACTION" ALKALOSIS AFTER DIURESIS OF EDEMATOUS PATIENTS WITH ETHACRYNIC ACID

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

“Pulse” methylprednisolone therapy in the treatment of severe glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

DIODRAST AND INULIN CLEARANCES IN NEPHROTIC CHILDREN WITH SUPERNORMAL UREA CLEARANCES.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Cyclophosphamide in the treatment of idiopathic lipoid nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Sterility and testicular atrophy related to cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Height and weight at menarche and a hypothesis of menarche

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Chlorambucil in steroid-dependent nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Dense deposit disease: a variant of membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Editorial: Focal glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Extramembranous glomerulonephritis in children: report of 50 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Quartan malarial nephrotic syndrome. Collaborative clinicopathological study in Nigerian children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Recurrence of idiopathic nephrotic syndrome after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

The nephrotic syndrome in the first year of life: is a pathologic classification possible?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Lipoid nephrosis and focal sclerosis distinct entities or spectrum of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

The nephrotic syndrome in children. I. Clinical response to nitrogen mustard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Nephrotic syndrome. A hypercoagulable state

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

The treatment of the nephrotic syndrome with steroids in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Thrombosis of the pulmonary arteries and the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Liver ultrastructural and biochemical changes in the prenephrotic stage of aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Nephrotic syndrome in association with renal vein thrombosis in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Thrombosis, nephrosis, and corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Pregnancy in patients who have had the idiopathic nephrotic syndrome in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Cell-mediated immunity in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Mesangiocapillary glomerulonephritis: Changes in glomerular morphology with long-term alternate-day prednisone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Long-term assessment of cyclophosphamide therapy for nephrosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Recurrence of membranoproliferative glomerulonephritis following kidney transplantation. Serum complement component studies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Immunologic aspects of the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Cyclophosphamide Therapy in the Nephrotic Syndrome in Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

The finger-nails in chronic hypoalbuminaemia; a new physical sign

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Lymphocytotoxins in primary renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Thyroxine metabolism in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Thyroid function in nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Long-term follow-up of children with steroid-responsive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Minimal-lesion nephrotic syndrome with early resistance to steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

ALTERNATE-DAY STEROID THERAPY FOR NEPHROTIC CHILDREN

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Primary peritonitis and the nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Late nonresponsiveness to steroids in children with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

Clinicopathological study of nephrotic syndrome in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933357-0

7 January 2021

10.1016/S0031-3955(16)33357-0

Identifiers

DOI

0 references

1 reference